Swiss National Bank’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.52M	Hold	128,600	–	–	﹤0.01%	1741
2025 Q4	$4M	Buy	128,600 +17,900	+16%	+$491K	﹤0.01%	1482
2025 Q3	$2.39M	Buy	110,700 +1,800	+2%	+$32.5K	﹤0.01%	1764
2025 Q2	$1.52M	Buy	108,900 +1,400	+1%	+$19K	﹤0.01%	1942
2025 Q1	$1.45M	Sell	107,500 -5,100	-5%	-$86.9K	﹤0.01%	1950
2024 Q4	$2.16M	Buy	112,600 +4,500	+4%	+$97.8K	﹤0.01%	1810
2024 Q3	$2.46M	Buy	108,100 +15,500	+17%	+$253K	﹤0.01%	1742
2024 Q2	$1.2M	Buy	92,600 +9,700	+12%	+$134K	﹤0.01%	2075
2024 Q1	$1.45M	Buy	82,900 +15,700	+23%	+$304K	﹤0.01%	2019
2023 Q4	$1.46M	Buy	67,200 +800	+1%	+$12.6K	﹤0.01%	2026
2023 Q3	$1.02M	Buy	66,400 +5,700	+9%	+$109K	﹤0.01%	2237
2023 Q2	$1.44M	Sell	60,700 -4,400	-7%	-$113K	﹤0.01%	2101
2023 Q1	$1.66M	Sell	65,100 -7,100	-10%	-$228K	﹤0.01%	1954
2022 Q4	$2.11M	Buy	72,200 +4,800	+7%	+$111K	﹤0.01%	1864
2022 Q3	$1.38M	Buy	67,400 +30,700	+84%	+$552K	﹤0.01%	2128
2022 Q2	$425K	Buy	+36,700	New	+$493K	﹤0.01%	2652